These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 25689507)

  • 1. Conserved surface accessible nucleoside ABC transporter component SP0845 is essential for pneumococcal virulence and confers protection in vivo.
    Saxena S; Khan N; Dehinwal R; Kumar A; Sehgal D
    PLoS One; 2015; 10(2):e0118154. PubMed ID: 25689507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae.
    Gor DO; Ding X; Briles DE; Jacobs MR; Greenspan NS
    Infect Immun; 2005 Mar; 73(3):1304-12. PubMed ID: 15731027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with components of two iron uptake ABC transporters protects mice against systemic Streptococcus pneumoniae infection.
    Brown JS; Ogunniyi AD; Woodrow MC; Holden DW; Paton JC
    Infect Immun; 2001 Nov; 69(11):6702-6. PubMed ID: 11598041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Immunoprotective Proteins of Streptococcus pneumoniae Identified by Opsonophagocytosis Killing Screen.
    Wang Y; Wen Z; Pan X; Briles DE; He Y; Zhang JR
    Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29891544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective Immune Responses Elicited by Fusion Protein Containing PsaA and PspA Fragments.
    Lu J; Sun T; Wang D; Dong Y; Xu M; Hou H; Kong FT; Liang C; Gu T; Chen P; Sun S; Lv X; Jiang C; Kong W; Wu Y
    Immunol Invest; 2015; 44(5):482-96. PubMed ID: 26107747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant PhpA protein, a unique histidine motif-containing protein from Streptococcus pneumoniae, protects mice against intranasal pneumococcal challenge.
    Zhang Y; Masi AW; Barniak V; Mountzouros K; Hostetter MK; Green BA
    Infect Immun; 2001 Jun; 69(6):3827-36. PubMed ID: 11349048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotype-Independent Protection Against Invasive Pneumococcal Infections Conferred by Live Vaccine With
    Jang AY; Ahn KB; Zhi Y; Ji HJ; Zhang J; Han SH; Guo H; Lim S; Song JY; Lim JH; Seo HS
    Front Immunol; 2019; 10():1212. PubMed ID: 31191555
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of pneumococcal disease in mice immunized with conserved surface-accessible proteins.
    Hamel J; Charland N; Pineau I; Ouellet C; Rioux S; Martin D; Brodeur BR
    Infect Immun; 2004 May; 72(5):2659-70. PubMed ID: 15102774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The factor H-binding fragment of PspC as a vaccine antigen for the induction of protective humoral immunity against experimental pneumococcal sepsis.
    Ricci S; Janulczyk R; Gerlini A; Braione V; Colomba L; Iannelli F; Chiavolini D; Oggioni MR; Björck L; Pozzi G
    Vaccine; 2011 Oct; 29(46):8241-9. PubMed ID: 21911026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A.
    Langermann S; Palaszynski SR; Burlein JE; Koenig S; Hanson MS; Briles DE; Stover CK
    J Exp Med; 1994 Dec; 180(6):2277-86. PubMed ID: 7964500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational selection of broadly cross-reactive family 2 PspA molecules for inclusion in chimeric pneumococcal vaccines.
    Converso TR; Goulart C; Rodriguez D; Darrieux M; Leite LCC
    Microb Pathog; 2017 Aug; 109():233-238. PubMed ID: 28602840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A bivalent pneumococcal histidine triad protein D-choline-binding protein A vaccine elicits functional antibodies that passively protect mice from Streptococcus pneumoniae challenge.
    Ochs MM; Williams K; Sheung A; Lheritier P; Visan L; Rouleau N; Proust E; de Montfort A; Tang M; Mari K; Hopfer R; Gallichan S; Brookes RH
    Hum Vaccin Immunother; 2016 Nov; 12(11):2946-2952. PubMed ID: 27392182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A putative amino acid ABC transporter substrate-binding protein, NMB1612, from Neisseria meningitidis, induces murine bactericidal antibodies against meningococci expressing heterologous NMB1612 proteins.
    Hung MC; Humbert MV; Laver JR; Phillips R; Heckels JE; Christodoulides M
    Vaccine; 2015 Aug; 33(36):4486-94. PubMed ID: 26207592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection with conditionally virulent Streptococcus pneumoniae Δpab strains induces antibody to conserved protein antigens but does not protect against systemic infection with heterologous strains.
    Chimalapati S; Cohen J; Camberlein E; Durmort C; Baxendale H; de Vogel C; van Belkum A; Brown JS
    Infect Immun; 2011 Dec; 79(12):4965-76. PubMed ID: 21947774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with polyamine transport protein PotD protects mice against systemic infection with Streptococcus pneumoniae.
    Shah P; Swiatlo E
    Infect Immun; 2006 Oct; 74(10):5888-92. PubMed ID: 16988268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with Pneumococcal Surface Protein K of Nonencapsulated Streptococcus pneumoniae Provides Protection in a Mouse Model of Colonization.
    Keller LE; Luo X; Thornton JA; Seo KS; Moon BY; Robinson DA; McDaniel LS
    Clin Vaccine Immunol; 2015 Nov; 22(11):1146-53. PubMed ID: 26311246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal Structure and Pathophysiological Role of the Pneumococcal Nucleoside-binding Protein PnrA.
    Abdullah MR; Batuecas MT; Jennert F; Voß F; Westhoff P; Kohler TP; Molina R; Hirschmann S; Lalk M; Hermoso JA; Hammerschmidt S
    J Mol Biol; 2021 Jan; 433(2):166723. PubMed ID: 33242497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the antibody response elicited by immunization with pneumococcal surface protein A (PspA) as recombinant protein or DNA vaccine and analysis of protection against an intranasal lethal challenge with Streptococcus pneumoniae.
    Vadesilho CF; Ferreira DM; Moreno AT; Chavez-Olortegui C; Machado de Avila RA; Oliveira ML; Ho PL; Miyaji EN
    Microb Pathog; 2012; 53(5-6):243-9. PubMed ID: 22981893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PrtA immunization fails to protect against pulmonary and invasive infection by Streptococcus pneumoniae.
    Hsu CF; Hsiao CH; Tseng SF; Chen JR; Liao YJ; Chen SJ; Lin CS; Sytwu HK; Chuang YP
    Respir Res; 2018 Sep; 19(1):187. PubMed ID: 30253765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against pneumococcal infection elicited by immunization with multiple pneumococcal heat shock proteins.
    Cao J; Zhang X; Gong Y; Zhang Y; Cui Y; Lai X; Yin Y; Li M; Li D; Zhang L
    Vaccine; 2013 Aug; 31(35):3564-71. PubMed ID: 23727004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.